Feedback / Questions
Piqray (alpelisib) - Novartis
Alpelisib: Initiation of P3 trials for HER2+ breast cancer/TNBC/ovarian cancer/head and neck cancer in 2020
(Novartis)
-
Dec 6, 2019 -
R&D Day
New P3 trial
https://www.novartis.com/sites/www.novartis.com/files/2019-12-05-novartis-r-d-day-investor-presentation.pdf
Dec 6, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious